Jpmorgan Chase & Co »

Telomir Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $150 121 1.25
2026-03-31 $138 121 1.14
2025-03-31 $30k 9.3k 3.23
2024-12-31 $171k 41k 4.12
2024-09-30 $22k 3.5k 6.42
2024-06-30 $9.9k 2.1k 4.81
2024-03-31 $14k 2.6k 5.23